Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetically actuated microrobotic system for sequential treatment of biofilm.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Enhancing cancer vaccine efficacy via electrostatic engineering of an FcγR-targeted protein.

Frontiers in immunology·2026
Same author

[Retracted] Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.

International journal of oncology·2026
Same author

Correction: SPHK1 promotes bladder cancer metastasis via PD-L2/c-Src/FAK signaling cascade.

Cell death & disease·2026
Same author

Atypical Dual-Task Cost and Reduced Attentional Neural Modulation in Parkinson's Disease With Freezing of Gait.

Neurorehabilitation and neural repair·2026
Same author

Spatial integration of protein and chromosomal states reveals early copy number changes and genotype-associated immune neighborhoods in serous ovarian cancer evolution.

Cancer discovery·2026

Related Experiment Video

Updated: Mar 6, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K

Recent progress in GM-CSF-based cancer immunotherapy.

Wan-Lun Yan1,2, Kuan-Yin Shen2,3, Chun-Yuan Tien1,2

  • 1Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.

Immunotherapy
|March 18, 2017
PubMed
Summary

Granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances antitumor immunity by promoting myeloid cell and dendritic cell differentiation. This review details GM-CSF-based cancer immunotherapy strategies and its role in regulating the tumor microenvironment.

Keywords:
GM-CSFcancer immunotherapyvaccine

More Related Videos

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Related Experiment Videos

Last Updated: Mar 6, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

22.1K
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

12.3K
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

8.5K

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Cancer immunotherapy is a rapidly advancing field.
  • Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a cytokine that promotes myeloid cell differentiation and is crucial for dendritic cell development.
  • Dendritic cells are vital for presenting tumor antigens to prime cytotoxic T lymphocytes, initiating antitumor immune responses.

Purpose of the Study:

  • To review current strategies for GM-CSF-based cancer immunotherapy.
  • To discuss the role of GM-CSF in modulating the tumor microenvironment.
  • To provide recommendations for clinical applications of GM-CSF in cancer treatment.

Main Methods:

  • Review of existing literature on GM-CSF in cancer immunotherapy.
  • Analysis of various GM-CSF-based therapeutic approaches.
  • Evaluation of GM-CSF's function in immune cell differentiation and tumor microenvironment regulation.

Main Results:

  • GM-CSF can be utilized as an immunostimulatory adjuvant to induce antitumor immunity.
  • Several strategies exist for GM-CSF-based immunotherapy, including monotherapy, cancer cell vaccines, antigen-fused protein vaccines, DNA vaccines, and combination therapies.
  • GM-CSF plays a role in regulating immunosuppression within the tumor microenvironment.

Conclusions:

  • GM-CSF is a versatile cytokine with significant potential in cancer immunotherapy.
  • Various GM-CSF-based strategies show promise for eliciting antitumor immune responses.
  • Further research and strategic implementation of GM-CSF are recommended for optimizing cancer treatment outcomes.